Scott Dunseth Myers Viridian Therapeutics, Inc.\De (VRDN) insider trading activity

Scott Dunseth Myers is Chief Executive Officer of Viridian Therapeutics, Inc.\DE. Currently has a direct ownership of 259,500 shares of VRDN, which is worth approximately $5.05 Million. The most recent transaction as insider was on Apr 12, 2023, when has been sold 4,000 shares (Common Stock) at a price of $25.37 per share, resulting in proceeds of $101,480. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 260K

0% 3M change

0% 12M change

Total Value Held $5.05 Million

Scott Dunseth Myers Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 12 2023	BUY Open market or private purchase	$101,480 $25.37 p/Share	4,000 Added 1.52%	259,500 Common Stock
Mar 13 2023	BUY Open market or private purchase	$160,325 $29.15 p/Share	5,500 Added 2.11%	255,500 Common Stock
Feb 06 2023	BUY Grant, award, or other acquisition	-	250,000 Added 50.0%	250,000 Common Stock

Also insider at

AMAG

AMAG PHARMACEUTICALS, INC.

President & CEO

SELB

SELECTA BIOSCIENCES INC Healthcare

Director

HARP

Harpoon Therapeutics, Inc. Healthcare

DVAX

DYNAVAX TECHNOLOGIES CORP Healthcare

ZNTL

Zentalis Pharmaceuticals, Inc. Healthcare

Director

SDM